No Rock Bottom Required: Every Proven Way Out of Alcohol Use Disorder, and How to Pick Yours

Alcohol treatment is not one doorway marked rehab. It includes safer withdrawal care, medications, therapy, outpatient and residential services, mutual help, and goals ranging from abstinence to meaningful reduction. The right first step depends on risk, not how dramatic your story sounds.

In 2025, only 2.6% of people age 12 or older with past-year alcohol use disorder received a medication for it during that year.1 That number does not mean everyone with AUD needs medicine. It means most people are never offered a conversation about a proven option.

You do not need a catastrophe, a particular label, or someone else’s definition of rock bottom. You need an honest look at what alcohol is doing and a safe next step.

What matters most

• Screeners can open a conversation, but they do not diagnose you or decide whether home withdrawal is safe.
• Abruptly stopping after sustained heavy drinking can cause seizures, delirium, or death. Check withdrawal risk first.
• Naltrexone and acamprosate have the strongest first-line medication support for many adults, but the best fit depends on goals, opioids, liver and kidney health, and adherence.
• Therapy, medication, mutual help, and practical changes can be combined. Treatment is not a loyalty test.
• A lapse is information for revising the plan, not proof that treatment or the person failed.

Zoom

A self-check is a door, not a diagnosis

The three-question AUDIT-C asks about drinking frequency, typical quantity, and heavy-drinking occasions. Common U.S. primary-care thresholds are 4 or more for men and 3 or more for women, but wording, scoring thresholds, sex and gender assumptions, and clinical context vary.2 A positive result means a fuller assessment is worthwhile. It is not a diagnosis.

DSM-5-TR describes AUD through 11 possible symptoms over 12 months, including drinking more than intended, unsuccessful efforts to cut down, craving, time spent drinking or recovering, role problems, hazardous use, continued use despite consequences, tolerance, and withdrawal. Two to three symptoms are categorized as mild, four to five as moderate, and six or more as severe.3 Quantity alone neither proves nor rules out AUD.

A practical self-review looks at loss of control, hidden drinking, worsening sleep or mood, medication safety, work, school, driving, and relationships. It also asks whether shaking, sweating, nausea, or intense anxiety appears as alcohol wears off, and whether more alcohol is needed for the same effect. Those answers help identify the next conversation.

Screening should lead to a conversation about function and safety, not an argument over a label. A clinician may ask about the largest amount, speed of drinking, blackouts, morning use, prior attempts to stop, injuries, driving, work or school changes, pregnancy, other substances, and the timing of mood symptoms. They may also review medications, blood pressure, liver and kidney health, nutrition, sleep, and suicide risk.

Bring a truthful estimate rather than a perfect diary. A standard U.S. drink is roughly 12 ounces of 5% beer, 5 ounces of 12% wine, or 1.5 ounces of 40% spirits, but cans, pours, cocktails, and high-alcohol products often contain more than one. The point is to help a clinician estimate exposure, not to create a safe maximum for someone with withdrawal risk.

Safety gate: could withdrawal be dangerous?

Withdrawal risk rises with prior withdrawal seizure or delirium, repeated withdrawals, sustained heavy use, current withdrawal signs, older age, major medical illness, head injury, benzodiazepine or other sedative use, and an unsafe setting without reliable support.4 Pregnancy does not by itself make withdrawal more severe, but it is a reason to seek a higher level of care. No single checklist captures every risk.

Clinicians may use PAWSS along with history and examination to predict complicated withdrawal. CIWA-Ar can track symptoms in an appropriate clinical setting. It can be confounded by infection, psychiatric symptoms, communication difficulties, or other illness. Neither tool should be self-administered as permission to detox alone.

Do not test withdrawal risk by yourself

Get medical advice before abruptly stopping if you drink heavily most days, have withdrawal symptoms when alcohol falls, have ever had a withdrawal seizure or delirium, use benzodiazepines or sedatives, are pregnant, have major medical illness, or lack a safe monitoring plan. Call 911 for a seizure, severe confusion, hallucinations with agitation, inability to wake, trouble breathing, collapse, or immediate danger.4

What medical withdrawal management can and cannot do

Withdrawal care begins with history, vital signs, examination, medication and substance review, and sometimes laboratory testing. Benzodiazepines are standard treatment when indicated because they reduce seizure and delirium risk. Thiamine is important when deficiency is possible. Fluids, electrolytes, nausea treatment, and management of other illnesses may be needed.4

Not every withdrawal requires hospitalization. Some clinician-selected, lower-risk patients can be monitored in ambulatory care with reliable follow-up and support. Higher risk, severe symptoms, unstable health, pregnancy, or an unsafe environment may require a hospital or supervised withdrawal setting.

Withdrawal management is a bridge, not ongoing AUD treatment. It can get someone safely through the acute period. It does not by itself change craving, cues, depression, housing, relationships, or the learned role alcohol has taken.

A monitored outpatient plan is still medical care. It usually requires a dependable way to contact the team, transportation, a safe place, a person who can notice deterioration, and the ability to return for reassessment. Symptoms can escalate after an initially mild presentation. Someone who is vomiting repeatedly, becoming confused, hallucinating, unable to take medication, or developing unstable vital signs needs a higher level of care.

Thiamine deserves special attention because heavy alcohol exposure and poor nutrition can lead to Wernicke encephalopathy. Confusion, abnormal eye movements, or severe gait trouble requires urgent evaluation. Fluids alone do not treat thiamine deficiency, and a person need not show the full classic triad.

The medications many people are never offered

Medication choice is about fit, not a winner-take-all ranking. A 2023 systematic review of 118 trials and 20,976 participants found numbers needed to treat to prevent return to any drinking of 11 (95% CI, 1 to 32) for acamprosate and 18 (95% CI, 4 to 32) for oral naltrexone 50 mg daily. For oral naltrexone and return to heavy drinking, the NNT was 11 (95% CI, 5 to 41). These are group averages with wide uncertainty, not personal guarantees.5

Naltrexone blocks opioid receptors. A clinician must review fentanyl, heroin, buprenorphine, methadone, tramadol, opioid pain medicines, and foreseeable surgery or injury care. Starting it with opioids in the body can precipitate withdrawal, and it can block opioid analgesia. Never hide opioid use to obtain it. Opioid tolerance also falls while naltrexone is being taken. After it is stopped, a previously usual opioid dose can cause a life-threatening overdose, and trying to override the blockade with larger opioid doses is especially dangerous.

Acamprosate is cleared through the kidneys and is usually started after withdrawal when abstinence has begun. Disulfiram does not make heavy drinking safe. Alcohol can hide in mouthwash, sauces, or medicines, and the reaction can include flushing, vomiting, low blood pressure, chest symptoms, and worse.

Oral and injectable naltrexone solve different practical problems. A daily tablet is easier to stop if side effects occur and has the clearest evidence base for several drinking outcomes. A monthly injection avoids daily remembering but requires an appointment, injection tolerance, and insurance or access planning. Neither formulation treats acute withdrawal or reverses intoxication.

Naltrexone and liver disease require nuance. It is not automatically forbidden for every abnormal liver test, and untreated heavy drinking also injures the liver. A clinician weighs current hepatic status, alternatives, monitoring, and benefit. The opioid review remains nonnegotiable because blocked pain treatment or precipitated withdrawal can be dangerous.

Acamprosate’s three-times-daily schedule can be difficult, but its lack of opioid blockade and primary kidney clearance may make it useful in the right person. It does not treat acute withdrawal and works best as part of an abstinence plan after alcohol has stopped.

Disulfiram is sometimes described as a deterrent, not an anti-craving medicine. Its evidence is strongest when adherence is observed or highly reliable. A person must understand that a reaction with alcohol can occur for up to 14 days after the last tablet, and must disclose all medicines and medical conditions. It is a poor surprise treatment and should never be given without the person’s knowledge.

Topiramate can reduce heavy drinking for some people but cognitive slowing may be especially disruptive for a student, driver, or person already worried about memory. Pregnancy prevention and fetal risk need explicit clinician review. Gabapentin can be helpful in selected cases, yet sedation and respiratory risk rise with opioids or other depressants, and abrupt discontinuation after ongoing use can cause withdrawal. Baclofen should remain a specialist or guideline-informed choice because trial results and recommendations are mixed.

Semaglutide deserves interest, not hype. A nine-week 2025 phase 2 trial enrolled 48 non-treatment-seeking adults and found improvement in laboratory alcohol self-administration, craving, and some weekly outcomes, but not all.6 A 2026 randomized trial in 108 treatment-seeking adults with AUD and obesity found a larger reduction in heavy-drinking days over 26 weeks with semaglutide plus CBT than with placebo plus CBT.7 A separate 50-person trial of oral semaglutide missed its primary cue-craving outcome but reduced heavy-drinking days and several secondary measures.8 GLP-1 drugs are not approved for AUD, and these selected studies do not support self-treatment.

Therapies that change behavior and environment

Cognitive behavioral therapy maps triggers, thoughts, feelings, and behavior, then practices different responses. Motivational enhancement helps a person clarify their own reasons and confidence for change rather than arguing them into it. A meta-analysis of trials in alcohol and other substance use disorders found CBT plus medication better than usual care plus medication, but it did not outperform another evidence-based therapy plus medication.9

Community reinforcement makes sober or lower-risk life more rewarding by changing routines, relationships, recreation, and work supports. Couples and family approaches can improve communication and reduce patterns that maintain use when participation is safe.

CRAFT, or Community Reinforcement and Family Training, teaches family members to reinforce non-drinking behavior, stop protecting alcohol use from every consequence, communicate more effectively, care for their own safety, and invite treatment without confrontation. Trials suggest it can improve treatment entry for a loved one who initially refuses, but studies are relatively small and heterogeneous.10

Contingency management provides tangible reinforcement for a defined behavior. Reviews describe strong evidence in some substance-use disorders, alongside fewer and smaller AUD-specific trials that often depend on a reliable biomarker and on program design. It should not be presented as universally available or superior.

Therapy has to reach the moments when alcohol usually wins. That may mean rehearsing how to leave a gathering, treating insomnia without sedatives, planning an answer to a relative, changing the drive home, or learning to notice the first thought that turns a lapse into a week. Skills become more useful through practice than through agreement in a quiet office.

Motivational interviewing is sometimes misunderstood as a soft alternative to treatment. Its purpose is to reduce a tug-of-war and help the person say why change matters in their own words. It can coexist with clear medical advice. A clinician can say, “Withdrawal may be dangerous” while still respecting autonomy about the longer-term goal.

Family participation should be safe and voluntary. Couples work is not appropriate when coercive control or violence makes disclosure dangerous. CRAFT does not ask a family member to police every breath or absorb every consequence. It includes self-care, boundaries, and reinforcement of healthy behavior.

Where treatment happens

Standard outpatient care may include a primary-care prescriber, addiction clinician, therapist, or integrated team. Intensive outpatient programs offer more hours and structure while a person lives at home. Partial hospitalization provides still more daytime support. Residential programs supply a substance-free setting and daily structure. Hospitals manage severe withdrawal and unstable medical or psychiatric conditions.

Level of care reflects medical risk, psychiatric needs, ability to function, recovery environment, and response to prior treatment. It is not a measure of moral seriousness. Telehealth is a delivery method that can support medication, therapy, or group care; it is not a clinical level by itself.

Residential care can be valuable when the home environment is saturated with alcohol, when daily structure is needed, or when outpatient care repeatedly cannot contain risk. It is not automatically more effective because it is more intense or expensive. What happens after discharge, including medication continuity, appointments, housing, work, and community support, often determines whether gains survive the transition.

Outpatient care can also be substantial. A person may see a prescriber, individual therapist, group program, and peer specialist while staying connected to family and work. Intensive outpatient and partial-hospital programs add hours and monitoring without overnight residence. Insurance language and local program names vary, so a level should be chosen by actual services and safety capacity.

Matching a plan to the person

A useful first plan answers five questions. Is withdrawal possible? What is the person’s current goal? Which medical and psychiatric conditions change safety? What support is realistically available? How will the plan be reviewed if it does not work?

Someone seeking reduction who has no withdrawal history may begin with outpatient assessment, tracking, naltrexone if appropriate, and therapy focused on high-risk situations. Someone with a strong abstinence goal after managed withdrawal may prefer acamprosate, a structured program, and mutual help. A person using opioid pain medicine needs a path that does not assume naltrexone is available. These are examples of reasoning, not prescriptions.

Preference is clinical information. A medicine that conflicts with a person’s goal or daily routine may not be taken. A group that feels unsafe will not provide belonging. A program that requires transportation the person lacks is not accessible care. Shared decision-making is not lowering the standard; it is how evidence reaches an actual life.

Co-occurring psychiatric symptoms should be treated in parallel. Waiting for alcohol use to be perfectly resolved can prolong depression, trauma symptoms, ADHD impairment, or bipolar instability. Treating only mood while ignoring withdrawal and drinking risk is also incomplete. Integrated care creates one plan with clear roles.

Progress can be measured in more than abstinence: fewer heavy-drinking days, longer alcohol-free periods, medication adherence, kept appointments, safer transportation, improved sleep, restored work, and reduced conflict all matter. The measure must still be honest. A reduction that leaves repeated blackouts or withdrawal may not be safe enough.

The plan also needs a failure condition. Decide in advance what will prompt a higher level of care: a seizure, escalating withdrawal, repeated blackouts, suicidal thinking, inability to take medication, loss of housing, or continued heavy drinking despite the current plan. Escalation is not punishment. It is a response to new information.

Conversely, improvement should not end care abruptly. Medication duration, therapy frequency, and program intensity can be reviewed over time. A gradual step-down with clear return points is safer than disappearing from support the moment a crisis passes.

The most useful plan is therefore specific, reachable, medically safe, and revisable. It tells the person what to do today and what evidence will change tomorrow’s decision.

It also names who will help interpret that evidence safely before risk escalates.

Abstinence, reduction, and harm reduction

Abstinence is the safest goal during pregnancy, when withdrawal and relapse patterns are severe, when alcohol interacts dangerously with health or medication, or when attempts at controlled drinking repeatedly fail. For other people, fewer heavy-drinking days and lower total exposure can reduce harm and become a bridge to further change. A clinician can help make the goal specific and measurable.

Targeted, or as-needed, naltrexone has evidence in selected people who are reducing drinking. The phrase “Sinclair method” refers to a branded approach that pairs naltrexone with anticipated drinking and claims pharmacologic extinction. The broader evidence does not prove a certain extinction process, and U.S. targeted use is off-label. A reader should not be told to drink so treatment can work. Opioid contraindications still apply, and medication never makes heavy drinking safe.

Mutual help, apps, and sober-curious spaces

AA, SMART Recovery, LifeRing, Women for Sobriety, Buddhist-inspired groups, secular meetings, and online communities can add belonging, structure, and people who recognize the pattern. Apps can support tracking and coping. Alcohol-free events can rebuild a social life without making every gathering a test.

These supports are not interchangeable with withdrawal care or medication management. They can be combined. Two Drunks in Akron compares their history, fit, and evidence.

The first 90 days

Early change can be uneven. Sleep may worsen before it improves. Anxiety, low mood, cue-driven craving, vivid dreams, irritability, and relationship strain can surface. The term post-acute withdrawal syndrome, or PAWS, is used for persistent or fluctuating symptoms after acute withdrawal, but definitions are inconsistent and a scoping review found the overall strength of treatment evidence to be low.11 It should not become a catch-all that hides depression, bipolar disorder, sleep apnea, trauma, medication effects, or another condition.

Plan for the time of day, place, people, and emotions most linked to drinking. Make alcohol harder to access if safe. Schedule food, sleep, medication, appointments, and contact with someone who knows the plan. If drinking occurs, ask what preceded it, whether medication or support was missed, whether withdrawal risk changed, and whether a higher level of care is needed.

Craving is often a wave rather than a command. It can rise with a cue, peak, and change even without drinking. A plan can include leaving the setting, contacting someone, eating, delaying a purchase, using a prescribed medication as directed, or moving into a structured environment. None of these steps proves that the urge was imaginary.

Relationships may lag behind biological recovery. Family members can remain watchful, angry, or exhausted after alcohol stops. Trust is rebuilt through repeated behavior, not demanded as a reward for a few sober days. Family therapy or peer support can give everyone a place to work without making one person responsible for policing the other.

Work, housing, transportation, childcare, and insurance are treatment variables. A theoretically ideal program that cannot be attended is not an effective plan. Ask about evening, telehealth, low-cost, and medication-only entry points, then build upward if needed.

Severe depression, suicidal thinking, mania, psychosis, or escalating withdrawal needs urgent evaluation. A period of abstinence also lowers tolerance, so returning to a previous drinking amount can cause greater intoxication and a higher risk of injury or overdose.

What Kind of Help Fits This Moment?

Four-rung help ladder

1. On your own, after the safety gate: Track drinks and triggers, make the next day alcohol-free only if withdrawal is not suspected, and use a validated screening conversation as a prompt for care.
2. With support: Tell a trusted person, try a mutual-help meeting, use a quit-oriented tool, or choose an alcohol-free setting.
3. With a clinician: Ask for withdrawal-risk assessment, medication options, therapy, and coordinated mental-health care. Riverside County CARES line, 24 hours: 800-499-3008. San Bernardino County SUD Helpline, 24 hours: 800-968-2636.1213
4. Emergency:
   • Call 911 for seizure, severe confusion, inability to wake, breathing trouble, collapse, or dangerous behavior.
   • Call or text 988 for suicidal crisis.
   • Riverside County 24-hour mobile crisis response: 951-686-HELP.
   • San Bernardino County Community Crisis Response Team: 800-398-0018.
   • SAMHSA’s National Helpline, a treatment-referral line rather than an emergency line: 1-800-662-HELP (4357).

Frequently asked questions

Do I have to call myself an alcoholic to get help?

No. AUD is a clinical diagnosis, and treatment does not require a personal identity label. You can ask about sleep, withdrawal, medication, or safer drinking without joining a particular culture.

Do I have to stop completely, or can cutting down count?

Meaningful reduction can reduce harm for some people. Abstinence is safer in several medical situations and when moderation repeatedly fails. The goal should be revisited as risk and experience change.

Can I detox at home?

Some lower-risk people receive clinician-monitored ambulatory care, but an article cannot determine eligibility. Prior severe withdrawal, current symptoms, heavy sustained use, medical illness, pregnancy, sedatives, or unsafe support can make unsupervised withdrawal dangerous.

Which AUD medication works best?

Naltrexone and acamprosate have the strongest first-line support for many adults, but neither is best for everyone. Drinking goal, opioid use, liver and kidney health, side effects, dosing burden, and preference determine fit.

What if I drink again after treatment starts?

Tell the treatment team and protect immediate safety. One episode can reveal a trigger, medication problem, or need for more support. It does not erase progress or require abandoning treatment.

One specific first action

If withdrawal might be possible, call a clinician or treatment access line before you stop. If it is not, make one appointment and ask directly: “Could I have alcohol use disorder, and are medication and therapy options appropriate for me?”

Help is appropriate before catastrophe. Community support can make the plan easier to return to, and the next article helps you choose one: Two Drunks in Akron.

This article is education, not diagnosis or a detoxification plan. Medication and level-of-care decisions require a clinician who knows your health, alcohol pattern, other substances, and goals.

Related reading on NP FADY

• The Loan Shark in the Bottle: How Alcohol Borrows Pleasure From Your Brain and Charges Interest
• Two Drunks in Akron: The Story of AA, What the Evidence Says, and the Secular Roads That Grew From It
• Kratom Explained: Uses, Risks, Addiction, and Warning Signs
• Treating Kratom Dependence and Addiction: What Recovery Looks Like

References

1. Substance Abuse and Mental Health Services Administration. Results from the 2025 National Survey on Drug Use and Health: Annual National Report. Published July 27, 2026. https://www.samhsa.gov/data/sites/default/files/reports/rpt57150/2025-nsduh-annual-national-html/2025-nsduh-annual-national.htm

2. U.S. Preventive Services Task Force. Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions. Final recommendation statement, November 13, 2018. An update is in progress; a draft recommendation was posted August 5, 2025. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/unhealthy-alcohol-use-in-adolescents-and-adults-screening-and-behavioral-counseling-interventions

3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision. American Psychiatric Association Publishing; 2022.

4. American Society of Addiction Medicine. The ASAM Clinical Practice Guideline on Alcohol Withdrawal Management. J Addict Med. 2020;14(3S Suppl 1):1-72. doi:10.1097/ADM.0000000000000668. https://www.asam.org/quality-care/clinical-guidelines/alcohol-withdrawal-management-guideline

5. McPheeters M, O’Connor EA, Riley S, et al. Pharmacotherapy for Alcohol Use Disorder: A Systematic Review and Meta-Analysis. JAMA. 2023;330(17):1653-1665. doi:10.1001/jama.2023.19761. https://pmc.ncbi.nlm.nih.gov/articles/PMC10630900/

6. Hendershot CS, Bremmer MP, Paladino MB, et al. Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial. JAMA Psychiatry. 2025;82(4):395-405. doi:10.1001/jamapsychiatry.2024.4789. https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2829811

7. Klausen MK, et al. Once-weekly semaglutide versus placebo in patients with alcohol use disorder and comorbid obesity: a randomised, double-blind, placebo-controlled trial. The Lancet. 2026;407:1687-1698. doi:10.1016/S0140-6736(26)00305-3. Summarized in: National Institutes of Health. Adding weekly GLP-1 to cognitive behavioral therapy further reduces heavy drinking. April 30, 2026. https://www.nih.gov/news-events/news-releases/adding-weekly-glp-1-cognitive-behavioral-therapy-further-reduces-heavy-drinking

8. Schacht JP, Sakai JT, Raymond K, Shelton R. Oral Semaglutide for Alcohol Use Disorder: A Randomized Clinical Trial. Am J Psychiatry. 2026;183(9):636-645. doi:10.1176/appi.ajp.20260003. https://pubmed.ncbi.nlm.nih.gov/42522065/

9. Ray LA, Meredith LR, Kiluk BD, Walthers J, Carroll KM, Magill M. Combined Pharmacotherapy and Cognitive Behavioral Therapy for Adults With Alcohol or Substance Use Disorders: A Systematic Review and Meta-analysis. JAMA Network Open. 2020;3(6):e208279. doi:10.1001/jamanetworkopen.2020.8279. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2767358

10. Archer M, Harwood H, Stevelink S, Rafferty L, Greenberg N. Community reinforcement and family training and rates of treatment entry: a systematic review. Addiction. 2020;115(6):1024-1037. doi:10.1111/add.14901. https://pubmed.ncbi.nlm.nih.gov/31770469/

11. Bahji A, Crockford D, El-Guebaly N. Management of Post-Acute Alcohol Withdrawal: A Mixed-Studies Scoping Review. J Stud Alcohol Drugs. 2022;83(4):470-479. doi:10.15288/jsad.2022.83.470. https://pubmed.ncbi.nlm.nih.gov/35838423/

12. Riverside University Health System. Substance Use Prevention and Treatment Services. Accessed September 3, 2026. https://www.ruhealth.org/behavioral-health/sapt/services

13. San Bernardino County Department of Behavioral Health. Substance Use Disorder and Recovery Services. Accessed September 3, 2026. https://wp.sbcounty.gov/dbh/sudrs/

If you or someone you know is in crisis

• Call 911 or go to your nearest emergency room for any life-threatening emergency.
• 988 Suicide & Crisis Lifeline — call or text 988, available 24/7. En español: marque 988 y oprima 2. Veterans: 988 and press 1, or text 838255.
• Crisis Text Line — text HOME to 741741.
• The Trevor Project (crisis support for LGBTQ+ young people) — call 1-866-488-7386, or text START to 678-678.
• National Sexual Assault Hotline (RAINN) — call 1-800-656-HOPE (4673) or text HOPE to 64673; free, confidential, 24/7. Online chat at RAINN.org/hotline.
• National Domestic Violence Hotline — call 1-800-799-SAFE (7233) or text START to 88788; 24/7, help in 200+ languages. Online chat at TheHotline.org. If your phone or computer may be monitored, calling from a safer device is an option.
• Riverside County — Inland SoCal Crisis Helpline 951-686-HELP (4357), 24/7 (Inland SoCal United Way / 211+, in partnership with RUHS-BH); Community Access, Referral, Evaluation and Support (CARES) Line 800-499-3008, 24/7.
• San Bernardino County — Access Unit (Behavioral Health Helpline) 888-743-1478, 24/7; Mobile Crisis/CCRT 800-398-0018 (24/7, all ages) or text 909-420-0560. Arrowhead Regional Medical Center (ARMC) has a dedicated walk-in adolescent psychiatric ER (ages 13–17).
• Children under 13 — call 911 for immediate danger, contact your county's mobile crisis team (they respond to all ages), or go to the nearest pediatric emergency room.
• California Peer-Run Warm Line (non-crisis — someone to talk to) — call or text 1-855-600-WARM (9276); daytime and evening hours, not a 24/7 line.
• NP Fady (non-emergency) — for routine scheduling or questions, call (909) 707-6261. This line is not monitored for emergencies.